INIS
cancer
100%
barriers
91%
mycotoxins
76%
food
72%
humans
65%
toxins
62%
secretion
59%
diseases
57%
bacteria
55%
fusarium
47%
mice
47%
defense
46%
inflammation
46%
proteins
45%
modulation
45%
bladder
43%
peptides
41%
polyphenols
41%
host
39%
levels
36%
lactobacillus
35%
cytokines
35%
pathogens
33%
toxicity
32%
messenger-rna
30%
mixtures
29%
reviews
29%
escherichia coli
29%
therapy
27%
translocation
27%
doses
23%
tumors
23%
gastrointestinal tract
23%
cell cycle
22%
hepatomas
22%
control
21%
tissues
20%
production
20%
urinary tract
20%
molecules
19%
tea
19%
universities
19%
aflatoxin
19%
plasma
19%
liver
17%
breasts
17%
growth
17%
immunoglobulins
16%
animals
16%
oxidation
15%
Medicine and Dentistry
Health
39%
Combination Therapy
34%
Probiotic Agent
31%
Host
28%
Bacterium
26%
Diseases
25%
Pathogen
24%
Innate Immunity
23%
Immune Response
22%
Gut
21%
Zearalenone
20%
Urinary Tract Infection
20%
Hepatocellular Carcinoma
19%
Aflatoxin B1
19%
Endocrine Disruptor
19%
Human Cell
19%
Therapeutic Procedure
18%
Infection
18%
Cells
17%
Malignant Neoplasm
17%
Cytokine
16%
Lactobacillus rhamnosus
16%
Escherichia coli
16%
Breast Cancer
15%
Mucin
13%
Protein
12%
Gut Microbiota
10%
Gastrointestinal Tract
10%
Colon Cancer
10%
Immune System
10%
Development
10%
Bladder Cancer
9%
Cancer Model
9%
Endopeptidase La
9%
Gut Microbiome
9%
Biomedical Discipline
9%
Oncogene
9%
Proteinase
9%
Antiinfective Agent
9%
Immunology
9%
Survival
9%
Secretion (Process)
8%
Prebiotic Agent
8%
Functional Foods
8%
Chronic Liver Disease
8%
Tissues
7%
Motivation
7%
Mycotoxin
7%
Cell Growth
7%
Morbidity
7%
Pharmacology, Toxicology and Pharmaceutical Science
Vomitoxin
59%
Probiotic Agent
39%
Resveratrol
28%
Liver Cell Carcinoma
26%
Antiinfective Agent
22%
Zearalenone
22%
Endocrine Disruptor
21%
Diseases
20%
Toxicity
19%
Acid
19%
Oleic Acid
19%
Ochratoxin
19%
Toxin
19%
Infectious Agent
17%
Host
16%
Breast Cancer
15%
Intestine Flora
14%
Malignant Neoplasm
14%
Polyunsaturated Fatty Acid
11%
Urinary Tract Infection
10%
Infection
10%
Protein
10%
Pig
9%
Mouse
9%
Bladder Cancer
9%
Intestine Injury
8%
Placental Mammal
8%
Chronic Liver Disease
8%
Bacterium
8%
Morbidity
7%
Disease Severity
7%
Cell Cycle
7%
Cancer Growth
7%
Fusarium
7%
Cell Cycle Control
7%
Antioxidant
7%
Bacterial Infection
7%
Acute Pyelonephritis
6%
Cystitis
6%
Polypeptide Antibiotic Agent
6%
Side Effect
6%
Liver Cancer
6%
Messenger RNA
6%
Neoplasm
6%
Antibiotic Agent
6%
Mitogen Activated Protein Kinase
5%
Risk Assessment
5%
Defensin
5%
Human
5%
Clinical Study
5%